Results 161 to 170 of about 265,886 (307)

The Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer. [PDF]

Oncol Res
Petrella F, Cara A, Cassina EM, Libretti L, Pirondini E, Raveglia F, Sibilia MC, Tuoro A.   +7 more
europepmc   +1 more source

Effect of Interval Between Neoadjuvant Immunochemotherapy and Radical Resection of Non‐Small Cell Lung Cancer: A Multicenter, Retrospective Cohort Study

International Journal of Cancer, EarlyView.
The optimal timing of surgery after neoadjuvant immunochemotherapy (NICT) for locally advanced non‐small cell lung cancer (NSCLC) remains unclear. In this retrospective investigation, the impact of time interval on outcome was assessed among NSCLC patients who completed NICT before undergoing radical resection.
Jiayi Wang, Pingping Song, Yong Ge, Haitang Yang, Shuyuan Li, Ran Ma, Tianyue Ma, Shoujie Feng, Cheng Zhang, Teng Sun, Feng Yao, Jun Yi, Hao Zhang   +12 more
wiley   +1 more source

Editorial: Efficacy, safety and biomarkers of novel therapeutics and regimens in the peri-operative setting of bone and soft tissue sarcoma

Frontiers in Surgery, 2023
Qiyuan Bao, Qiyuan Bao
doaj   +1 more source

Predictive Value of Circulating Tumor Cells in Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer. [PDF]

Thorac Cancer
Yang J, Qin Z, Zhou Z, Liu J, Chen L, Mo Z, Liao M, Cui D, Wu K, Tang D, Chen J, Chen C.   +11 more
europepmc   +1 more source

The Predictive Value of the Tumor‐Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor‐Positive Breast Cancer

International Journal of Cancer, EarlyView.
Neoadjuvant endocrine therapy (NET) can help prevent metastases and improve survival in patients with hormone receptor‐positive (HR+) breast cancer. Identifying which HR+ patients will benefit from NET, however, remains challenging. Here, in a patient cohort in the Netherlands, the authors evaluated tumor‐stroma ratio (TSR) and magnetic resonance ...
Layla Andour, Sophie C. Hagenaars, Anne Florine de Groot, Elly M. M. Krol‐Warmerdam, Judith R. Kroep, Hans Marten Hazelbag, Gerrit‐Jan Liefers, Marieke E. Straver, Wilma E. Mesker   +8 more
wiley   +1 more source

Clinicopathological Predictors of Pathological Complete Response in HER2-Positive Breast Cancer Treated with Pertuzumab-Based Neoadjuvant Therapy: A Multicenter Real-World Study. [PDF]

Medicina (Kaunas)
Yıldız F, Karabuga B, Karatlı S, Yalınkılıç M, Deliktas Onur İ, Bilgic Koylu E, Soylu Kocoğlu S, Eraslan E, Ilhan Gülesen A, Erdur E, Yildirim OA, Gurler F, Yasar HA, Aslan F.   +13 more
europepmc   +1 more source

Neoadjuvant Atezolizumab and Chemotherapy for Non‐Squamous Non‐Small Cell Lung Cancer: Efficacy and Safety Results of an Open‐Label, Single‐Arm, Phase II Trial

International Journal of Cancer, EarlyView.
Surgery plus chemotherapy is a well‐established treatment protocol for resectable, locally advanced non‐small cell lung cancer (NSCLC). Nonetheless, survival gains remain limited, emphasizing the need for more effective treatments. Here, the authors evaluated a novel approach using a neoadjuvant immunotherapy‐chemotherapy regimen consisting of ...
Benedikt Niedermaier, Tilmann Bochtler, Florian Eichhorn, Raffaella Griffo, Laura V. Klotz, Michael Allgäuer, Albrecht Stenzinger, Helge Bischoff, Marc A. Schneider, Petros Christopoulos, Uwe Haberkorn, Claus Peter Heussel, Inka Zoernig, Felix J. F. Herth, Michael Thomas, Alexander Rölle, Hauke Winter, Axel Benner, Dirk Jaeger, Martin E. Eichhorn   +19 more
wiley   +1 more source

Corrigendum: Neoadjuvant tislelizumab combined with chemotherapy in locally advanced oral or oropharyngeal squamous cell carcinoma: a real−world retrospective study

Frontiers in Immunology
Wen-Jie Wu, Wen-Jie Wu, Wen-Jie Wu, Qian Liu, Qian Liu, Qian Liu, Pu-Gen An, Pu-Gen An, Pu-Gen An, Lin Wang, Lin Wang, Lin Wang, Jian-Yun Zhang, Jian-Yun Zhang, Jian-Yun Zhang, Yan Chen, Yan Chen, Yan Chen, Tong Zhang, Jie Zhang, Jie Zhang, Jie Zhang   +21 more
doaj   +1 more source

Editorial: Optimal perioperative management of urothelial carcinoma

Frontiers in Oncology, 2023
Ariane Holzman, Elliott Tokarski, Benjamin Pradère, Evanguelos Xylinas   +3 more
doaj   +1 more source

Endoscopic resection as a "resect-to-confirm" strategy after neoadjuvant downstaging for remnant gastric cancer. [PDF]

Endoscopy
Zuo X, Chen Q, Du C, Shao Q, Zhou J, Wang Z, Linghu E.   +6 more
europepmc   +1 more source